A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda

BMC Pregnancy and Childbirth

Pascal Magnussen¹  Josephine Birungi²  Stephanie Yanow⁴  Anthony K Mbonye³ 

[1] Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark;Uganda Virus Research Institute, Entebbe, Uganda;School of Public Health, College of Health Sciences, Makerere University & Commissioner Health Services, Ministry of Health, Box 7272, Kampala, Uganda;Provincial Laboratory for Public Health, University of Alberta, Edmonton, Alberta, Canada

关键词: Uganda;    Health-Trust Model;    Mama kit;    Adherence;    IPTp;    Malaria in pregnancy;   

Others  :  1137873
DOI  :  10.1186/1471-2393-13-178

 received in 2012-12-20, accepted in 2013-09-18,  发布年份 2013

【 摘 要 】

Background

Few women in Uganda access intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP). Previous studies have shown that high costs, frequent stock-out of drugs, supplies and poor quality of care are the greatest hindrance for women to access health services. In order to increase adherence to IPTp, we conceptualised an intervention that offset delivery care costs through providing a mama kit, created awareness on health benefits of IPTp and built trust between the provider and the client.

Methods

The new strategy was conceived along four constructs namely: 1) creating awareness by training midwives to explain the benefits of SP and the importance of adhering to the two doses of SP as IPTp to all pregnant women who attended ANC and consented to the study. Midwives were trained for two days in customer care and to provide a friendly environment. The pregnant women were also informed of the benefits of attending ANC and delivering at health facilities. 2) Each woman was promised a mama kit during ANC; 3) trust was built by showing the mama kit to each woman and branding it with her name; 4) keeping the promise by providing the mama kit when women came to deliver. The strategy to increase adherence to two doses of SP and encourage women to deliver at health facilities was implemented at two health facilities in Mukono district (Kawolo hospital and Mukono health centre IV). The inclusion criteria were women who: i) consented to the study and ii) were in the second trimester of pregnancy. All pregnant women in the second trimester (4-6 months gestation) who attended ANC and consented to participate in the study were informed of the benefits of SP, the importance of delivering at health facilities, were advised to attend the scheduled visits, promised a mama kit and ensured the kit was available at delivery. The primary outcome was the proportion of pregnant women adhering to a two dose SP regimen.

Results

A total of 2,276 women received the first dose of SP and 1,656 (72.8%) came back for the second dose. 1,069 women were involved in the evaluation (384 had participated in the intervention while 685 had not). The main reasons that enabled those who participated in the intervention to adhere to the two doses of IPTp and deliver at the study facilities were: an explanation provided on the benefits of IPTp and delivering at health facilities (25.1%), availability of a mama kit at delivery (24.6%), kind midwives (19.8%) and fearing complications of pregnancy (8.5%). Overall, 78.0% of these women reported that they were influenced to adhere to IPTp by the intervention. In a multivariable regression, nearby facility, P = 0. 007, promising a mama kit, P = 0.002, kind midwives, P = 0.0001 and husbands’ encouragement, P = 0.0001 were the significant factors influencing adherence to IPTp with SP.

Conclusion

The new strategy was a good incentive for women to attend scheduled ANC visits, adhere to IPTp and deliver at the study facilities. Policy implications include the urgent need for developing a motivation package based on the Health-Trust Model to increase access and adherence to IPTp.

【 授权许可】

   
2013 Mbonye et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]MOH (Ministry of Health): Health sector strategic plan III. Box 7272, Kampala, Uganda: Ministry of Health; 2010.
• [2]Uganda Bureau of Statistics: The Uganda demographic and health survey. Kampala, Uganda: Uganda Bureau of Statistics; 2011.
• [3]Mbonye AK, Neema S, Magnussen P: Treatment seeking practices for malaria in pregnancy among rural women in Mukono District, Uganda. J Bios Sci 2006, 38:221-237.
• [4]McCombie SC: Treatment seeking for malaria: a review of recent research. Soc Sci Med 1996, 6:933-945.
• [5]Ndyomugyenyi R, Neema S, Magnussen P: The use formal and informal services for Antenatal care and malaria treatment in rural Uganda. Health Policy Plan 1998, 13:94-104.
• [6]Ammoti-Kaguna , Nuwaha F: Factors influencing choice of delivery sites in Rakai district, Uganda. Soc Sci Med 2000, 50:200-213.
• [7]Mulogo EM, Witte K, Bajunirwe F, Nabukera SK, Muchunguzi C, Batwala VK, Bagenda F, Farr C, Barry S: Birth plans and health facility based delivery in rural Uganda. East Afr Med J 2006, 83:74-83.
• [8]Peltzer K, Mosala T, Shisana O, Nqeteko A: Utilization of delivery services in the context of prevention of HIV from mother-to child (PMTCT) in a rural community, South Africa. Curationis 2006, 29:54-61.
• [9]Bolam A, Manandha DS, Shrestha P, Elli M, Malla K, Costello AM: Factors affecting home delivery in the Kathmandu valley, Nepal. Health Pol & Plan 1998, 13:152-158.
• [10]Hodgkin D: Household characteristics affecting where mothers in rural Kenya. Economics 1996, 5:333-340.
• [11]Mbonye AK, Asimwe JB, Kabarangira J, Nanda G, Orinda V: Emergency obstetric care as the priority intervention to reduce maternal mortality in Uganda. Int J Gynecol & Obstet 2007, 96(3):220-225.
• [12]UNICEF/WHO/UNFPA: Guidelines for monitoring and availability and use of obstetric services. New York: UNICEF; 1997.
• [13]Xu K, Evans DB, Kadama P, Nabyonga J, Ogwal PO, Nabukhonzo P, Aguilar AM: Understanding the impact of eliminating user fees: utilization and catastrophic health expenditures in Uganda. Soc Sci Med 2006, 62:866-876.
• [14]Parise ME, Ayisi JG, Nahlen BL, Schultz LZ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW: Efficacy of sulphadoxine pyrimethamine for prevention of placental malaria in area of Kenya with a high prevalence of malaria and human immune-deficiency virus infection. Am J Trop Med Hyg 1998, 59:813-822.
• [15]Filler S, Kazembe P, Thigpen M, Macheso A, Parise M, Newman R, Steketee R, Hamel M: Randomized trial of 2-dose versus monthly sulfadoxine-pyremethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 2006, 194:286-293.
• [16]Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV: Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 2001, 358(9287):1027-1028.
• [17]Ministry of Health: Malaria treatment guidelines. Box 7272, Kampala, Uganda: Ministry of Health; 2010.
• [18]MOH (Ministry of Health): Reproductive health strategy (2000-2005). BOX 7272 Kampala, Uganda: Ministry of Health; 2003.
• [19]MOH (Ministry of Health): The road map to the reduction of maternal and neonatal health in Uganda. BOX 7272 Kampala, Uganda: Ministry of Health; 2006.
• [20]Mbonye AK, Bygbjerg I, Magnussen P: Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitaemia, anemia and low birth weight in Uganda. Int J Infect Dis 2008, 12(1):22-29.
• [21]Andersen R: Behavioral model of families' use of health services. Research Series No. 25. Chicago, IL: Center for Health Administration Studies, University of Chicago; 1968.
• [22]Becker MH: The health belief model and personal health behaviour. Health Educ.Monographs 1974, 2:4.